ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 23 filers reported holding ATYR PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $373,590 | -37.7% | 236,449 | -14.9% | 0.00% | – |
| Q2 2023 | $600,056 | +93.4% | 277,804 | +88.0% | 0.00% | – |
| Q1 2023 | $310,323 | +71568.1% | 147,773 | -25.3% | 0.00% | – |
| Q4 2022 | $433 | -99.9% | 197,692 | +16.7% | 0.00% | – |
| Q3 2022 | $508,000 | +21.5% | 169,360 | +14.7% | 0.00% | – |
| Q2 2022 | $418,000 | -61.4% | 147,596 | -27.0% | 0.00% | – |
| Q1 2022 | $1,082,000 | -36.1% | 202,284 | -10.8% | 0.00% | -100.0% |
| Q4 2021 | $1,694,000 | -16.8% | 226,712 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $2,036,000 | +88.9% | 224,279 | +1.5% | 0.00% | – |
| Q2 2021 | $1,078,000 | +275.6% | 220,928 | +243.1% | 0.00% | – |
| Q1 2021 | $287,000 | +287.8% | 64,400 | +236.6% | 0.00% | – |
| Q4 2020 | $74,000 | +19.4% | 19,130 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -16.2% | 19,130 | +15.0% | 0.00% | – |
| Q2 2020 | $74,000 | -5.1% | 16,630 | -40.4% | 0.00% | – |
| Q1 2020 | $78,000 | – | 27,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
| Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
| Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
| VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
| Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
| FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
| Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
| Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
| Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |